Aarti Pharmalabs Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	67.34	236.35	121.21	832.73	2.5
Short-Term Investments	-	491.23	706.82	-	-	-
Trading Asset Securities	-	-	-	509.9	-	-
Cash & Short-Term Investments	555.56	558.57	943.17	631.11	832.73	2.5
Cash Growth	-44.17%	-40.78%	49.45%	-24.21%	33209.36%	-
Accounts Receivable	-	5,754	5,193	4,501	3,767	-
Other Receivables	-	93.57	108.61	53.71	65.42	-
Receivables	-	5,858	5,315	4,567	3,893	-
Inventory	-	5,876	6,429	6,020	4,755	-
Prepaid Expenses	-	63.44	61.48	23.25	41.96	-
Other Current Assets	-	866.12	708.61	388.04	758.89	-
Total Current Assets	-	13,222	13,456	11,630	10,281	2.5
Property, Plant & Equipment	-	14,107	10,932	9,861	9,453	-
Long-Term Investments	-	292.41	367.8	355.25	322.26	-
Goodwill	-	17.81	17.81	17.81	17.81	-
Other Intangible Assets	-	984.4	752.74	398.5	223.65	-
Other Long-Term Assets	-	367.74	235.89	119.32	100.67	-
Total Assets	-	29,064	25,821	22,440	20,399	2.5
Accounts Payable	-	2,778	3,783	3,395	2,146	0.03
Accrued Expenses	-	509.18	373.34	143.44	87.83	-
Short-Term Debt	-	2,928	2,641	2,142	3,377	0.17
Current Portion of Long-Term Debt	-	-	-	-	3.42	-
Current Portion of Leases	-	50.94	44.91	4.45	12.44	-
Current Income Taxes Payable	-	11.45	-	35.15	75	-
Other Current Liabilities	-	292.66	101.83	286.65	104.8	0.02
Total Current Liabilities	-	6,570	6,944	6,006	5,807	0.22
Long-Term Debt	-	1,113	0.39	1.84	5.55	-
Long-Term Leases	-	116.69	166.59	5.32	15.32	-
Pension & Post-Retirement Benefits	-	8.31	6.18	5.47	-	-
Long-Term Deferred Tax Liabilities	-	1,284	1,079	788.38	706.7	-
Other Long-Term Liabilities	-	72.87	54.41	48.14	-	-
Total Liabilities	-	9,165	8,251	6,855	6,534	0.22
Common Stock	-	453.17	453.13	453.13	2.5	2.5
Additional Paid-In Capital	-	4,408	4,403	4,403	4,403	-
Retained Earnings	-	14,131	11,734	9,746	8,006	-0.22
Comprehensive Income & Other	-	906.85	979.81	982.06	1,453	-
Shareholders' Equity	20,462	19,899	17,570	15,585	13,865	2.28
Total Liabilities & Equity	-	29,064	25,821	22,440	20,399	2.5
Total Debt	6,747	4,208	2,853	2,153	3,414	0.17
Net Cash (Debt)	-6,192	-3,650	-1,909	-1,522	-2,581	2.33
Net Cash Growth	-	-	-	-	-	0.59%
Net Cash Per Share	-68.23	-40.24	-21.07	-16.79	-28.48	9.31
Filing Date Shares Outstanding	90.65	90.63	90.63	90.63	90.63	0.25
Total Common Shares Outstanding	90.65	90.63	90.63	90.63	90.63	0.25
Working Capital	-	6,651	6,513	5,624	4,475	2.28
Book Value Per Share	225.70	219.55	193.88	171.97	152.99	9.12
Tangible Book Value	19,317	18,897	16,800	15,169	13,623	2.28
Tangible Book Value Per Share	213.07	208.49	185.38	167.38	150.32	9.12
Land	-	841.46	779.38	669.32	641.01	-
Buildings	-	1,848	1,668	1,568	1,202	-
Machinery	-	14,218	12,789	11,610	9,941	-
Construction In Progress	-	3,066	784.97	622.04	1,652	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.